Virtu KCG Holdings LLC bought a new stake in EDAP TMS S.A. (NASDAQ:EDAP) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 35,601 shares of the medical equipment provider’s stock, valued at approximately $117,000. Virtu KCG Holdings LLC owned about 0.12% of EDAP TMS at the end of the most recent reporting period.

Separately, Essex Investment Management Co. LLC acquired a new position in EDAP TMS in the second quarter valued at about $172,000. 9.40% of the stock is owned by institutional investors.

A number of research firms have commented on EDAP. Zacks Investment Research raised shares of EDAP TMS from a “strong sell” rating to a “hold” rating in a research report on Wednesday, October 25th. HC Wainwright reissued a “buy” rating and set a $6.50 price target on shares of EDAP TMS in a research report on Monday, October 9th. Finally, ValuEngine raised shares of EDAP TMS from a “sell” rating to a “hold” rating in a research report on Friday, October 6th.

TRADEMARK VIOLATION NOTICE: This news story was originally posted by TheOlympiaReport and is owned by of TheOlympiaReport. If you are viewing this news story on another website, it was illegally copied and republished in violation of US & international trademark & copyright laws. The correct version of this news story can be accessed at

EDAP TMS (NASDAQ:EDAP) last issued its earnings results on Wednesday, August 23rd. The medical equipment provider reported ($0.05) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.02) by ($0.03). EDAP TMS had a positive return on equity of 10.31% and a negative net margin of 0.27%. The firm had revenue of $10.40 million for the quarter, compared to analysts’ expectations of $10.00 million. During the same quarter in the previous year, the firm posted $0.10 EPS. The firm’s revenue for the quarter was up 13.0% compared to the same quarter last year.


EDAP TMS SA (EDAP) is a holding company engaged in developing and marketing the Ablatherm and Focal One devices. The Company operates two divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) (including lithotripsy activities). The Company is developing HIFU technology for the treatment of certain other types of tumors.

Institutional Ownership by Quarter for EDAP TMS (NASDAQ:EDAP)

Receive News & Ratings for EDAP TMS S.A. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EDAP TMS S.A. and related companies with Analyst Ratings Network's FREE daily email newsletter.